Forest Laboratories is reaching settlements in a host of wrongful death and personal injury lawsuits filed by parents of children who took their antidepressants.
The New York-based pharmaceutical is taking the step a month after its St. Louis-based subsidiary, Forest Pharmaceuticals, pleaded guilty to criminal charges and agreed to pay more than $300 million in penalties stemming from its marketing and manufacturing practices. More than 50 lawsuits accuse Forest of concealing negative pediatric studies of the drug Celexa and aggressively marketing Celexa and its sister drug, Lexapro.
